These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25100380)

  • 1. Nonobese Young Females with Polycystic Ovary Syndrome have Nutritive Microvascular Dysfunction: A Pilot Study.
    Leão LM; Maranhão PA; Oliveira V; Villela NR; Bordallo MA; Borges MA; Bouskela E; Kraemer-Aguiar LG
    Endocr Pract; 2014 Dec; 20(12):1281-9. PubMed ID: 25100380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early postmenopausal women with cardiovascular risk factors improve microvascular dysfunction after acute estradiol administration.
    Clapauch R; Mecenas AS; Maranhão PA; Bouskela E
    Menopause; 2012 Jun; 19(6):672-9. PubMed ID: 22314638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in sexual function among women with polycystic ovary syndrome: a pilot study.
    Ferraresi SR; Lara LA; Reis RM; Rosa e Silva AC
    J Sex Med; 2013 Feb; 10(2):467-73. PubMed ID: 23210985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial-mediated microcirculatory responses to an acute estradiol test are influenced by time since menopause, cumulative hormone exposure, and vasomotor symptoms.
    Clapauch R; Mecenas AS; Maranhão PA; Bouskela E
    Menopause; 2010 Jul; 17(4):749-57. PubMed ID: 20395877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic nailfold videocapillaroscopy may be used for early detection of microvascular dysfunction in obesity.
    Maranhão PA; de Souza Md; Kraemer-Aguiar LG; Bouskela E
    Microvasc Res; 2016 Jul; 106():31-5. PubMed ID: 26969104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe chronic periodontitis is associated with endothelial and microvascular dysfunctions: a pilot study.
    Lira-Junior R; Figueredo CM; Bouskela E; Fischer RG
    J Periodontol; 2014 Dec; 85(12):1648-57. PubMed ID: 25019176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
    Lin XF; Wu RR; Du J; Liao YC; Du Y; Ye Y; Wang Y; Zhang XB; Wu C; Chen A
    Clin Exp Obstet Gynecol; 2015; 42(3):315-20. PubMed ID: 26152001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
    Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
    Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study.
    Romualdi D; Versace V; Tagliaferri V; De Cicco S; Immediata V; Apa R; Guido M; Lanzone A
    J Endocrinol Invest; 2019 Sep; 42(9):1089-1097. PubMed ID: 30847861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study.
    Tagliaferri V; Romualdi D; Guido M; Mancini A; De Cicco S; Di Florio C; Immediata V; Di Segni C; Lanzone A
    Eur J Endocrinol; 2016 Nov; 175(5):433-41. PubMed ID: 27511825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on BMI and subclinical hypothyroidism in adolescent girls first examined for amenorrhea or oligomenorrhea. The emerging role of polycystic ovary syndrome.
    Nezi M; Christopoulos P; Paltoglou G; Gryparis A; Bakoulas V; Deligeoroglou E; Creatsas G; Mastorakos G
    J Pediatr Endocrinol Metab; 2016 Jun; 29(6):693-702. PubMed ID: 27089404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
    Sanke S; Chander R; Jain A; Garg T; Yadav P
    JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine characteristics, body mass index and metabolic syndrome in women with polycystic ovary syndrome.
    Li J; Wu Q; Wang CC; Wang R; Ng EHY; Liu JP; Mol BWJ; Wu XK; Li WT;
    Reprod Biomed Online; 2019 Nov; 39(5):868-876. PubMed ID: 31444050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.